14259-55-3

Basic information

• Product Name: (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid
• Synonyms: (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid;Desacetyl asperulosidic acid;(1S,4aS,5S,7aS)-1-(β-D-Glucopyranosyloxy)-5-hydroxy-7-(hydroxymethyl)-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylic acid
• CAS NO: 14259-55-3
• Molecular Formula: C₁₆H₂₂O₁₁
• Molecular Weight: 390.33928
• Product Categories: chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract
• Mol File: 14259-55-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 744.1±60.0 °C(Predicted)
• Appearance: /
• Density: 1.73
• PKA: 4.34±0.70(Predicted)
• CAS DataBase Reference: (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid(14259-55-3)
• EPA Substance Registry System: (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid(14259-55-3)

Safety Data

• Hazardous Substances Data: 14259-55-3(Hazardous Substances Data)

Usage

Description

(1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid is a complex organic molecule characterized by a cyclopenta[c]pyran core structure. This molecule features a b-D-glucopyranosyloxy group attached to the carbon atom at position 1, a hydroxymethyl side chain, and multiple hydroxy and carboxylic acid functional groups. The presence of these functional groups suggests potential biological activity and medicinal applications, although further research is required to elucidate its full properties and uses.

Uses

Used in Pharmaceutical Industry:
(1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid is used as a potential pharmaceutical compound for its possible biological activity. The hydroxy and carboxylic acid groups, along with the glucopyranosyloxy moiety, may contribute to interactions with biological targets, making it a candidate for drug development. Further research is needed to explore its efficacy and safety in treating specific medical conditions.
Used in Drug Delivery Systems:
In the field of drug delivery, (1S,4aS,5S,7aS)-1-(b-D-Glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-(hydroxymethyl)cyclopenta[c]pyran-4-carboxylic acid could be utilized as a component in the design of drug delivery systems. Its functional groups may facilitate the attachment of therapeutic agents or enhance the solubility and bioavailability of drugs, improving their delivery to target tissues. The development of such systems would require extensive research and optimization to ensure effectiveness and biocompatibility.

Relevant articles and documents

An iridoid glucoside dimer and a non-glycosidic iridoid from the leaves of Lasianthus wallichii.

A new iridoid glucoside dimer (1) and a non-glycosidic iridoid (2) was isolated together with the known compounds, asperuloside (3), paederoside (4), daphylloside (5), citroside A (6) and benzyl 6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside (7), from the leaves of Lasianthus wallichii. The structures of the new compounds were elucidated by spectroscopic and chemical evidence.